This Might Be The Most Controversial Palantir Take Yet

Palantir Technologies (PLTR) has surged 141% year-to-date, prompting debate over its valuation. While some, like Jim Cramer, deem it 'ridiculously cheap' citing its exceptional 94% Rule of 40 score for growth and profitability, traditional metrics show PLTR trading at a 621x P/E and expanding price-to-sales multiples significantly above software peers. The article contends that institutional investors typically prioritize these traditional valuation methods over industry-specific metrics, suggesting PLTR is overvalued and current premium levels may prompt profit-taking rather than new allocation.

Analysis

Palantir Technologies (PLTR) presents a significant valuation conflict following its 141% year-to-date stock appreciation. On one hand, the company's performance according to the 'Rule of 40' is exceptional, with a score of 94% that combines revenue growth and profitability, surpassing any enterprise software peer with over $1 billion in revenue. This metric is the foundation of the bull case, suggesting the stock's premium is justified. However, this perspective is challenged by traditional valuation methods, which indicate the stock is severely overvalued. Palantir trades at a price-to-earnings (P/E) ratio of 621 and its price-to-sales (P/S) multiple is not only higher than any comparable business but is actively expanding. The analysis is skeptical of the Rule of 40's validity, noting Palantir's use of an adjusted operating margin that excludes non-cash expenses like stock-based compensation. The central thesis is that institutional investors are more likely to adhere to conventional valuation methodologies, which would flag PLTR as overbought, potentially leading to profit-taking and downward pressure on the stock rather than new allocations.

Key Decisions for Investors

• Investors should critically assess whether Palantir's superior 'Rule of 40' score justifies a valuation that is stretched on traditional metrics, such as its 621 P/E ratio, which institutional capital may find unsustainable.
• Given the stock's 141% year-to-date surge and expanding price-to-sales multiple, it may be prudent to consider trimming positions to realize gains, mitigating the risk of a correction driven by institutional profit-taking.
• Before initiating a position, scrutinize the quality of Palantir's reported profitability, particularly its use of adjusted non-GAAP figures, and determine if the growth outlook is durable enough to support its premium valuation relative to peers.